|
1997 Journal Article An open-label assessment of the impact of clozapine on biological, psychosocial and economic variablesChatterton, R and McGrath, J (1997). An open-label assessment of the impact of clozapine on biological, psychosocial and economic variables. Schizophrenia Research, 24 (1-2), 186-186. doi: 10.1016/S0920-9964(97)82529-7 |
|
1997 Journal Article Thought disorder and executive abilityMcGrath, John, Scheldt, Susan, Hengstberger, Peter and Dark, Frances (1997). Thought disorder and executive ability. Cognitive Neuropsychiatry, 2 (4), 303-314. doi: 10.1080/135468097396306 |
|
1997 Journal Article Schizophrenia.McGrath, J (1997). Schizophrenia.. Australian And New Zealand Journal of Psychiatry, 31 (6), 894-895. |
|
1997 Journal Article Ocular abnormalities in chronic schizophrenia: clinical implicationsSmith, D, Pantelis, C, McGrath, J, Tangas, C and Copolov, D (1997). Ocular abnormalities in chronic schizophrenia: clinical implications. Australian And New Zealand Journal of Psychiatry, 31 (2), 252-256. doi: 10.3109/00048679709073828 |
|
1997 Journal Article Schizophrenia genesis: the origins of madness.McGrath, J (1997). Schizophrenia genesis: the origins of madness.. Australian And New Zealand Journal of Psychiatry, 31 (6), 894-895. |
|
1996 Journal Article Pathological laughing and cryingDark, F. L., McGrath, J. J. and Ron, M. A. (1996). Pathological laughing and crying. Australian and New Zealand Journal of Psychiatry, 30 (4), 472-479. doi: 10.3109/00048679609065020 |
|
1996 Journal Article Dermatoglyphic a-b ridge count as a possible marker for developmental disturbance in schizophrenia: Replication in two samplesFananas, L., van Os, J., Hoyos, C., McGrath, J., Mellor, C. S. and Murray, R. (1996). Dermatoglyphic a-b ridge count as a possible marker for developmental disturbance in schizophrenia: Replication in two samples. Schizophrenia Research, 20 (3), 307-314. doi: 10.1016/0920-9964(95)00013-5 |
|
1996 Journal Article Formation of pyridinium species of haloperidol in human liver and brainEyles, D. W., McGrath, J. J. and Pond, S. M. (1996). Formation of pyridinium species of haloperidol in human liver and brain. Psychopharmacology, 125 (3), 214-219. doi: 10.1007/BF02247331 |
|
1996 Journal Article Evidence and tardive dyskinesiaSoares, Karla, McGrath, John and Adams, Clive (1996). Evidence and tardive dyskinesia. Lancet, 347 (9016), 1696-1697. doi: 10.1016/S0140-6736(96)91525-1 |
|
1996 Journal Article Incorporating lag effects in register-based age-of-onset distributions in schizophreniaWelham, J. L., Pemberton, M. R. and McGrath, J. J. (1996). Incorporating lag effects in register-based age-of-onset distributions in schizophrenia. Schizophrenia Research, 20 (1-2), 125-132. doi: 10.1016/0920-9964(95)00087-9 |
|
1996 Journal Article Neurogenesis in adult humanMurrell, Wayne, Bushell, Gillian R., Livesey, Jonathon, McGrath, John, MacDonald, Kelli P.A., Bates, Paul R. and Mackay Sim, Alan (1996). Neurogenesis in adult human. NeuroReport, 7 (6), 1189-1194. doi: 10.1097/00001756-199604260-00019 |
|
1995 Journal Article Minor physical anomalies in psychoses: Associations with clinical and putative aetiological variablesMcGrath, J. J., van Os, J., Hoyos, C., Jones, P. B., Harvey, I. and Murray, R. M. (1995). Minor physical anomalies in psychoses: Associations with clinical and putative aetiological variables. Schizophrenia Research, 18 (1), 9-20. doi: 10.1016/0920-9964(95)00016-X |
|
1995 Journal Article Month of birth, hemisphere of birth and schizophreniaMcGrath, J., Welham, J. and Pemberton, M. (1995). Month of birth, hemisphere of birth and schizophrenia. British Journal of Psychiatry, 167 (06), 783-785. doi: 10.1192/bjp.167.6.783 |
|
1995 Journal Article Remoxipride versus thioridazine in the treatment of first episodes of schizophrenia in drug-naive patients: A case for specific, low potency D-2 antagonistsLambert, T., Keks, N., McGrath, J., Catts, S., Hustig, H., Vaddadi, K., Burrows, G., Varghese, F., George, T., Kerr, K., Johnson, G., Burnett, P., Zorbas, A., Hill, C. and Copolov, D. (1995). Remoxipride versus thioridazine in the treatment of first episodes of schizophrenia in drug-naive patients: A case for specific, low potency D-2 antagonists. Human Psychopharmacology, 10 (6), 455-460. doi: 10.1002/hup.470100604 |
|
1995 Journal Article An open-label study of famotidine as a treatment for schizophreniaWhiteford, H. A., Stedman, T. J., McGrath, J. J., Welham, J. and Pond, S. (1995). An open-label study of famotidine as a treatment for schizophrenia. Journal of Psychiatry and Neuroscience, 20 (3), 239-240. |
|
1995 Journal Article An open-label study of famotidine as a treatment for schizophreniaWhiteford, HA, Stedman, TJ, McGrath, JJ, Welham, JL and Pond, S. (1995). An open-label study of famotidine as a treatment for schizophrenia. Journal of Psychiatry and Neuroscience, 20 (3), 239-240. |
|
1994 Journal Article Schizophrenia and the influenza epidemics of 1954, 1957 and 1959: A southern hemisphere studyMcGrath, J. J., Pemberton, M. R., Welham, J. L. and Murray, R. M. (1994). Schizophrenia and the influenza epidemics of 1954, 1957 and 1959: A southern hemisphere study. Schizophrenia Research, 14 (1), 1-8. doi: 10.1016/0920-9964(94)90002-7 |
|
1994 Journal Article The Australian multicentre double-blind comparative study of remoxipride and thioridazine in schizophreniaKeks, N., McGrath, J., Lambert, T., Catts, S., Vaddadi, K., Burrows, G., Varghese, F., George, T., Hustig, H., Burnett, P., Kerr, K., Zorbas, A., Hill, C., Stedman, T., Johnson, G., Leibert, B., Copolov, D., Mackenzie, M. and Dillenbeck, C. (1994). The Australian multicentre double-blind comparative study of remoxipride and thioridazine in schizophrenia. Acta Psychiatrica Scandinavica, 90 (5), 358-365. doi: 10.1111/j.1600-0447.1994.tb01607.x |
|
1994 Journal Article Quantitative analysis of two pyridinium metabolites of haloperidol in patients with schizophreniaEyles, D. W., McLennan, H. R., Jones, A., McGrath, J. J., Stedman, T. J. and Pond, S. M. (1994). Quantitative analysis of two pyridinium metabolites of haloperidol in patients with schizophrenia. Clinical Pharmacology and Therapeutics, 56 (5), 512-520. doi: 10.1038/clpt.1994.172 |
|
1994 Journal Article Schizophrenia and the Cochrane CollaborationAdams, C., Anderson, J., Awad, G., Cooper, S., Davidson, M., Essali, A., Indran, S., Jones, P., Lee, R., Mari, J., McGrath, J., Pantelis, C., Phillips, M., Puri, B., Spitzer, M. and Streiner, D. (1994). Schizophrenia and the Cochrane Collaboration. Schizophrenia Research, 13 (2), 185-187. doi: 10.1016/0920-9964(94)90101-5 |
